Dato-DXd lengthened the average time it took patients with HR-positive, HER2-low or -negative metastatic breast cancer to experience disease progression, study results showed. Patients with hormone ...
The PlayStation Vita has been getting quite a few free-to-play titles recently, with the likes of Judas Code and others. This week’s issue of Famitsu magazine reveals that a High School DxD game will ...
Dato-DXd significantly improved progression-free survival compared to chemotherapy in HR-positive, HER2-negative breast cancer patients. The study showed a 37% reduction in disease progression or ...
Treatment with datopotamab deruxtecan (Dato-DXd), a novel Trop-2 directed antibody-drug conjugate, was found to significantly improve progression-free survival in patients with metastatic non-small ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results